ID

30432

Description

Efficacy Study of Escitalopram for Depression in Patients With Diabetes; ODM derived from: https://clinicaltrials.gov/show/NCT00650897

Link

https://clinicaltrials.gov/show/NCT00650897

Keywords

  1. 6/5/18 6/5/18 -
Copyright Holder

See clinicaltrials.gov

Uploaded on

June 5, 2018

DOI

To request one please log in.

License

Creative Commons BY 4.0

Model comments :

You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.

Itemgroup comments for :

Item comments for :

In order to download data models you must be logged in. Please log in or register for free.

Eligibility Major Depression NCT00650897

Eligibility Major Depression NCT00650897

Inclusion Criteria
Description

Inclusion Criteria

Alias
UMLS CUI
C1512693
age 18 years or older.
Description

Age

Data type

boolean

Alias
UMLS CUI [1]
C0001779
diagnosis of type-1 or type-2 diabetes mellitus (excluding gestational diabetes) by a specialist at least 6 months prior to the study.
Description

Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus, Non-Insulin-Dependent | Gestational Diabetes Excluded

Data type

boolean

Alias
UMLS CUI [1]
C0011854
UMLS CUI [2]
C0011860
UMLS CUI [3,1]
C0085207
UMLS CUI [3,2]
C0332196
current diagnosis of major depression based on dsm-iv criteria .
Description

Major Depressive Disorder

Data type

boolean

Alias
UMLS CUI [1]
C1269683
hamilton depression rating scale (hamd) baseline score > 17
Description

Hamilton rating scale for depression

Data type

boolean

Alias
UMLS CUI [1]
C0451203
available for 14-weeks of treatment and all evaluations.
Description

Protocol Compliance

Data type

boolean

Alias
UMLS CUI [1]
C0525058
able to understand study rules and procedures and willing to sign written informed consent for study participation.
Description

Informed Consent

Data type

boolean

Alias
UMLS CUI [1]
C0021430
Exclusion Criteria
Description

Exclusion Criteria

Alias
UMLS CUI
C0680251
competence: not competent to understand and sign informed consent forms and/or to understand and answer the evaluations.
Description

Informed Consent incompetent | Protocol Compliance incompetent

Data type

boolean

Alias
UMLS CUI [1,1]
C0021430
UMLS CUI [1,2]
C0231190
UMLS CUI [2,1]
C0525058
UMLS CUI [2,2]
C0231190
psychiatric exclusions: one or more of the following: alcohol or substance abuse or dependence in past 6 months; psychotic symptoms or history of psychosis; bipolar disorder; organic brain syndrome; significant suicide risk; homicidal thoughts.
Description

Substance Use Disorders | Substance Dependence | Psychotic symptom | Psychotic Disorders | Bipolar Disorder | Organic brain syndrome | At risk for suicide | Homicidal thoughts

Data type

boolean

Alias
UMLS CUI [1]
C0038586
UMLS CUI [2]
C0038580
UMLS CUI [3]
C0871189
UMLS CUI [4]
C0033975
UMLS CUI [5]
C0005586
UMLS CUI [6]
C0029221
UMLS CUI [7]
C0563664
UMLS CUI [8]
C0455204
medical exclusions: known intolerance or hypersensitivity to escitalopram or other ssri; pregnancy; breastfeeding; women of childbearing potential not using adequate contraception; significant renal or hepatic dysfunction (such that demands medical workup and/or regular follow up); resting heart rate less than 40/minute (or 50/minute if symptomatic); uncontrolled hypertension (systolic blood pressure >180 mm hg or diastolic blood pressure >100 mm hg); any acute or unstable medical condition that might interfere with the safe conduct of the study.
Description

Intolerance to Escitalopram | Hypersensitivity Escitalopram | Intolerance to Selective Serotonin Reuptake Inhibitors | Selective serotonin re-uptake inhibitor allergy | Pregnancy | Breast Feeding | Gender Contraceptive methods Absent | Renal dysfunction | Liver Dysfunction | Requirement Work up | Requirement Follow-up Regular | RESTING HEART RATE | Resting heart rate Symptomatic | Uncontrolled hypertension | Systolic Pressure | Diastolic blood pressure | Medical condition Interferes with Completion of clinical trial | Medical condition Unstable Interferes with Completion of clinical trial

Data type

boolean

Alias
UMLS CUI [1,1]
C1744706
UMLS CUI [1,2]
C1099456
UMLS CUI [2,1]
C0020517
UMLS CUI [2,2]
C1099456
UMLS CUI [3,1]
C1744706
UMLS CUI [3,2]
C0360105
UMLS CUI [4]
C0570765
UMLS CUI [5]
C0032961
UMLS CUI [6]
C0006147
UMLS CUI [7,1]
C0079399
UMLS CUI [7,2]
C0700589
UMLS CUI [7,3]
C0332197
UMLS CUI [8]
C3279454
UMLS CUI [9]
C0086565
UMLS CUI [10,1]
C1514873
UMLS CUI [10,2]
C0750430
UMLS CUI [11,1]
C1514873
UMLS CUI [11,2]
C1522577
UMLS CUI [11,3]
C0205272
UMLS CUI [12]
C1821417
UMLS CUI [13,1]
C1821417
UMLS CUI [13,2]
C0231220
UMLS CUI [14]
C1868885
UMLS CUI [15]
C0871470
UMLS CUI [16]
C0428883
UMLS CUI [17,1]
C3843040
UMLS CUI [17,2]
C0521102
UMLS CUI [17,3]
C2732579
UMLS CUI [18,1]
C3843040
UMLS CUI [18,2]
C0443343
UMLS CUI [18,3]
C0521102
UMLS CUI [18,4]
C2732579
concomitant medication(s) exclusion: current use (within 2 weeks of enrollment) of one or more of the following: antidepressants; regular benzodiazepine; neuroleptics; anticonvulsants; reserpine; guanethidine; clonidine; methyldopa.
Description

Antidepressive Agents | Benzodiazepines Regular | Antipsychotic Agents | Anticonvulsants | Reserpine | Guanethidine | Clonidine | Methyldopa

Data type

boolean

Alias
UMLS CUI [1]
C0003289
UMLS CUI [2,1]
C0005064
UMLS CUI [2,2]
C0205272
UMLS CUI [3]
C0040615
UMLS CUI [4]
C0003286
UMLS CUI [5]
C0035179
UMLS CUI [6]
C0018318
UMLS CUI [7]
C0009014
UMLS CUI [8]
C0025741

Similar models

Eligibility Major Depression NCT00650897

Name
Type
Description | Question | Decode (Coded Value)
Data type
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
age 18 years or older.
boolean
C0001779 (UMLS CUI [1])
Diabetes Mellitus, Insulin-Dependent | Diabetes Mellitus, Non-Insulin-Dependent | Gestational Diabetes Excluded
Item
diagnosis of type-1 or type-2 diabetes mellitus (excluding gestational diabetes) by a specialist at least 6 months prior to the study.
boolean
C0011854 (UMLS CUI [1])
C0011860 (UMLS CUI [2])
C0085207 (UMLS CUI [3,1])
C0332196 (UMLS CUI [3,2])
Major Depressive Disorder
Item
current diagnosis of major depression based on dsm-iv criteria .
boolean
C1269683 (UMLS CUI [1])
Hamilton rating scale for depression
Item
hamilton depression rating scale (hamd) baseline score > 17
boolean
C0451203 (UMLS CUI [1])
Protocol Compliance
Item
available for 14-weeks of treatment and all evaluations.
boolean
C0525058 (UMLS CUI [1])
Informed Consent
Item
able to understand study rules and procedures and willing to sign written informed consent for study participation.
boolean
C0021430 (UMLS CUI [1])
Item Group
C0680251 (UMLS CUI)
Informed Consent incompetent | Protocol Compliance incompetent
Item
competence: not competent to understand and sign informed consent forms and/or to understand and answer the evaluations.
boolean
C0021430 (UMLS CUI [1,1])
C0231190 (UMLS CUI [1,2])
C0525058 (UMLS CUI [2,1])
C0231190 (UMLS CUI [2,2])
Substance Use Disorders | Substance Dependence | Psychotic symptom | Psychotic Disorders | Bipolar Disorder | Organic brain syndrome | At risk for suicide | Homicidal thoughts
Item
psychiatric exclusions: one or more of the following: alcohol or substance abuse or dependence in past 6 months; psychotic symptoms or history of psychosis; bipolar disorder; organic brain syndrome; significant suicide risk; homicidal thoughts.
boolean
C0038586 (UMLS CUI [1])
C0038580 (UMLS CUI [2])
C0871189 (UMLS CUI [3])
C0033975 (UMLS CUI [4])
C0005586 (UMLS CUI [5])
C0029221 (UMLS CUI [6])
C0563664 (UMLS CUI [7])
C0455204 (UMLS CUI [8])
Intolerance to Escitalopram | Hypersensitivity Escitalopram | Intolerance to Selective Serotonin Reuptake Inhibitors | Selective serotonin re-uptake inhibitor allergy | Pregnancy | Breast Feeding | Gender Contraceptive methods Absent | Renal dysfunction | Liver Dysfunction | Requirement Work up | Requirement Follow-up Regular | RESTING HEART RATE | Resting heart rate Symptomatic | Uncontrolled hypertension | Systolic Pressure | Diastolic blood pressure | Medical condition Interferes with Completion of clinical trial | Medical condition Unstable Interferes with Completion of clinical trial
Item
medical exclusions: known intolerance or hypersensitivity to escitalopram or other ssri; pregnancy; breastfeeding; women of childbearing potential not using adequate contraception; significant renal or hepatic dysfunction (such that demands medical workup and/or regular follow up); resting heart rate less than 40/minute (or 50/minute if symptomatic); uncontrolled hypertension (systolic blood pressure >180 mm hg or diastolic blood pressure >100 mm hg); any acute or unstable medical condition that might interfere with the safe conduct of the study.
boolean
C1744706 (UMLS CUI [1,1])
C1099456 (UMLS CUI [1,2])
C0020517 (UMLS CUI [2,1])
C1099456 (UMLS CUI [2,2])
C1744706 (UMLS CUI [3,1])
C0360105 (UMLS CUI [3,2])
C0570765 (UMLS CUI [4])
C0032961 (UMLS CUI [5])
C0006147 (UMLS CUI [6])
C0079399 (UMLS CUI [7,1])
C0700589 (UMLS CUI [7,2])
C0332197 (UMLS CUI [7,3])
C3279454 (UMLS CUI [8])
C0086565 (UMLS CUI [9])
C1514873 (UMLS CUI [10,1])
C0750430 (UMLS CUI [10,2])
C1514873 (UMLS CUI [11,1])
C1522577 (UMLS CUI [11,2])
C0205272 (UMLS CUI [11,3])
C1821417 (UMLS CUI [12])
C1821417 (UMLS CUI [13,1])
C0231220 (UMLS CUI [13,2])
C1868885 (UMLS CUI [14])
C0871470 (UMLS CUI [15])
C0428883 (UMLS CUI [16])
C3843040 (UMLS CUI [17,1])
C0521102 (UMLS CUI [17,2])
C2732579 (UMLS CUI [17,3])
C3843040 (UMLS CUI [18,1])
C0443343 (UMLS CUI [18,2])
C0521102 (UMLS CUI [18,3])
C2732579 (UMLS CUI [18,4])
Antidepressive Agents | Benzodiazepines Regular | Antipsychotic Agents | Anticonvulsants | Reserpine | Guanethidine | Clonidine | Methyldopa
Item
concomitant medication(s) exclusion: current use (within 2 weeks of enrollment) of one or more of the following: antidepressants; regular benzodiazepine; neuroleptics; anticonvulsants; reserpine; guanethidine; clonidine; methyldopa.
boolean
C0003289 (UMLS CUI [1])
C0005064 (UMLS CUI [2,1])
C0205272 (UMLS CUI [2,2])
C0040615 (UMLS CUI [3])
C0003286 (UMLS CUI [4])
C0035179 (UMLS CUI [5])
C0018318 (UMLS CUI [6])
C0009014 (UMLS CUI [7])
C0025741 (UMLS CUI [8])

Please use this form for feedback, questions and suggestions for improvements.

Fields marked with * are required.

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial